logo
Diamondback Energy Extends Credit Agreement and Raises Dividend

Diamondback Energy Extends Credit Agreement and Raises Dividend

Yahoo18 hours ago

Diamondback Energy, Inc. (NASDAQ:FANG) is one of the best dividend stocks according to Jim Cramer.
The company amended its Credit Agreement with Wells Fargo Bank on June 12, 2025. With the interest rates and certain fees reduced, the maturity date has been postponed to June 12, 2030.
A pipeline worker overseeing the flow of crude oil into storage tanks from an integrated water system.
Diamondback Energy, Inc. (NASDAQ:FANG) is a Texas-based independent oil and natural gas company, engaged in the business of hydrocarbon exploration. The focus of the company is on acquiring, developing, exploring, and exploiting unconventional, onshore oil and natural gas reserves, primarily in the Permian Basin in West Texas.
With a market cap of $43.55 billion, Diamondback Energy, Inc. (NASDAQ:FANG) has announced an extension to its credit agreement on Thursday. The company's existing credit facility had a maturity date of June 2, 2028. By successfully amending its credit terms with its lenders, the company has managed to extend the maturity date to June 12, 2030. The company's subsidiary, Viper Energy, saw its board approve a 10% increase in base dividends after a $4.1 billion all-stock acquisition of Sitio Royalties Corp.
Following these developments, Wells Fargo reiterated their Buy rating for the stock on June 16, 2025, with a price target of $208.
Diamondback Energy, Inc. (NASDAQ:FANG) offers a dividend yield of 3.51%, with a payout ratio of 38.62%, signaling a self-sufficiency in meeting the dividend obligations. The company has had a consistent dividend payment record since 2018.
While we acknowledge the potential of FANG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: andDisclosure. None.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Investing in HRnetGroup (SGX:CHZ) five years ago would have delivered you a 73% gain
Investing in HRnetGroup (SGX:CHZ) five years ago would have delivered you a 73% gain

Yahoo

time13 minutes ago

  • Yahoo

Investing in HRnetGroup (SGX:CHZ) five years ago would have delivered you a 73% gain

When we invest, we're generally looking for stocks that outperform the market average. And in our experience, buying the right stocks can give your wealth a significant boost. For example, long term HRnetGroup Limited (SGX:CHZ) shareholders have enjoyed a 34% share price rise over the last half decade, well in excess of the market return of around 21% (not including dividends). On the other hand, the more recent gains haven't been so impressive, with shareholders gaining just 1.4%, including dividends. So let's assess the underlying fundamentals over the last 5 years and see if they've moved in lock-step with shareholder returns. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. HRnetGroup's earnings per share are down 2.4% per year, despite strong share price performance over five years. So it's hard to argue that the earnings per share are the best metric to judge the company, as it may not be optimized for profits at this point. Therefore, it's worth taking a look at other metrics to try to understand the share price movements. We note that the dividend is higher than it was previously - always nice to see. Maybe dividend investors have helped support the share price. We'd posit that the revenue growth over the last five years, of 6.8% per year, would encourage people to invest. The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image). Take a more thorough look at HRnetGroup's financial health with this free report on its balance sheet. It is important to consider the total shareholder return, as well as the share price return, for any given stock. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. As it happens, HRnetGroup's TSR for the last 5 years was 73%, which exceeds the share price return mentioned earlier. The dividends paid by the company have thusly boosted the total shareholder return. HRnetGroup shareholders gained a total return of 1.4% during the year. Unfortunately this falls short of the market return. On the bright side, the longer term returns (running at about 12% a year, over half a decade) look better. Maybe the share price is just taking a breather while the business executes on its growth strategy. Most investors take the time to check the data on insider transactions. You can click here to see if insiders have been buying or selling. Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Singaporean exchanges. — Investing narratives with Fair Values Vita Life Sciences Set for a 12.72% Revenue Growth While Tackling Operational Challenges By Robbo – Community Contributor Fair Value Estimated: A$2.42 · 0.1% Overvalued Vossloh rides a €500 billion wave to boost growth and earnings in the next decade By Chris1 – Community Contributor Fair Value Estimated: €78.41 · 0.1% Overvalued Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth By Unike – Community Contributor Fair Value Estimated: $325.55 · 0.6% Undervalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store